These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2040249)

  • 21. The effect of covariance between the K alpha and the K beta lead peak concentrations on the uncertainty in the result of in vivo (109)Cd KXRF bone lead measurement.
    Brito JA
    Phys Med Biol; 2006 Dec; 51(23):6125-39. PubMed ID: 17110775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone lead measured by X-ray fluorescence: epidemiologic methods.
    Hu H; Aro A; Rotnitzky A
    Environ Health Perspect; 1995 Feb; 103 Suppl 1(Suppl 1):105-10. PubMed ID: 7621788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance appraisals of digital spectroscopy systems for the measurement of bone lead.
    Bateman SN; Pejović-Milić A; Stronach IM; McNeill FE; Chettle DR
    Appl Radiat Isot; 2000; 53(4-5):647-50. PubMed ID: 11003502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing uncertainties of in vivo bone lead measurement using a (109)Cd K X-ray fluorescence clover leaf geometry detector system.
    Behinaein S; Chettle DR; Marro L; Malowany M; Fisher M; Fleming DE; Healey N; Inskip M; Arbuckle TE; McNeill FE
    Environ Sci Process Impacts; 2014 Dec; 16(12):2742-51. PubMed ID: 25322174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contamination of in vivo bone-lead measurements.
    Todd AC
    Phys Med Biol; 2000 Jan; 45(1):229-40. PubMed ID: 10661594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calibration of (109)Cd KXRF systems for in vivo bone lead measurements: the guiding role of the assumptions for least-squares regression in practical problem solving.
    de Brito JA; de Carvalho ML; Chettle DR
    Phys Med Biol; 2009 Feb; 54(4):919-34. PubMed ID: 19141884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrections to "How to calculate lead concentration and concentration uncertainty in XRF in vivo bone lead analysis" by Kondrashov and Rothenberg.
    Todd AC; Moshier EL; Arnold M; Aro A; Chettle DR; McNeill FE; Nie H; Flemming DE; Stronach IM
    Appl Radiat Isot; 2003 Jan; 58(1):41-50; author reply 51-4. PubMed ID: 12485662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vivo measurement of bone lead stores by 109Cd K X-ray fluorescence in a non-human primate (Macaca mulatta).
    McNeill FE; Todd AC; Fowler BA; Laughlin NK
    Basic Life Sci; 1993; 60():315-8. PubMed ID: 8110136
    [No Abstract]   [Full Text] [Related]  

  • 30. L-shell x-ray fluorescence measurements of lead in bone: theoretical considerations.
    Todd AC
    Phys Med Biol; 2002 Feb; 47(3):491-505. PubMed ID: 11848124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo quantification of lead in bone with a portable x-ray fluorescence system--methodology and feasibility.
    Nie LH; Sanchez S; Newton K; Grodzins L; Cleveland RO; Weisskopf MG
    Phys Med Biol; 2011 Feb; 56(3):N39-51. PubMed ID: 21242629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification to the Monte Carlo N-particle code for simulating direct, in vivo measurement of stable lead in bone.
    Lodwick CJ; Spitz HB
    Health Phys; 2008 Jun; 94(6):519-26. PubMed ID: 18469585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-ray fluorescence analysis of lead in bone.
    Todd AC; Landrigan PJ
    Environ Health Perspect; 1993 Nov; 101(6):494-5. PubMed ID: 8137777
    [No Abstract]   [Full Text] [Related]  

  • 34. Measurements of Strontium Levels in Human Bone In Vivo Using Portable X-ray Fluorescence (XRF).
    Specht AJ; Mostafaei F; Lin Y; Xu J; Nie LH
    Appl Spectrosc; 2017 Aug; 71(8):1962-1968. PubMed ID: 28756702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty.
    Hu H; Milder FL; Burger DE
    Environ Health Perspect; 1991 Aug; 94():107-10. PubMed ID: 1954919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo evaluation of a coherent normalization procedure to quantify in vivo finger strontium XRS measurements.
    Heirwegh CM; Chettle DR; Pejovicc-Milicc A
    Med Phys; 2012 Feb; 39(2):832-41. PubMed ID: 22320793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to calculate lead concentration and concentration uncertainty in XRF in vivo bone lead analysis.
    Kondrashov VS; Rothenberg SJ
    Appl Radiat Isot; 2001 Dec; 55(6):799-803. PubMed ID: 11761103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monte Carlo simulations of in vivo K-shell X-ray fluorescence bone lead measurement and implications for radiation dosimetry.
    Ahmed N; Fleming DE; O'Meara JM
    Appl Radiat Isot; 2006 Sep; 64(9):1036-42. PubMed ID: 16766194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of bone-density on in vivo K x-ray fluorescence bone-lead measurements.
    Lodwick CJ; Lodwick JC; Spitz HB
    Health Phys; 2011 May; 100(5):502-7. PubMed ID: 21451320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calibration and characterization of a digital X-ray fluorescence bone lead system.
    Fleming DE; Forbes TA
    Appl Radiat Isot; 2001 Oct; 55(4):527-32. PubMed ID: 11545507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.